KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Treasury Shares (2016 - 2025)

Regeneron Pharmaceuticals has reported Treasury Shares over the past 12 years, most recently at $18.6 billion for Q4 2025.

  • Quarterly results put Treasury Shares at $18.6 billion for Q4 2025, up 22.72% from a year ago — trailing twelve months through Dec 2025 was $18.6 billion (up 22.72% YoY), and the annual figure for FY2025 was $18.6 billion, up 22.72%.
  • Treasury Shares for Q4 2025 was $33.7 million at Regeneron Pharmaceuticals, up from $32.7 million in the prior quarter.
  • Over the last five years, Treasury Shares for REGN hit a ceiling of $33.7 million in Q4 2025 and a floor of -$17.7 million in Q2 2021.
  • Median Treasury Shares over the past 5 years was $22.3 million (2022), compared with a mean of $17.3 million.
  • Biggest five-year swings in Treasury Shares: surged 545.87% in 2021 and later rose 14.36% in 2024.
  • Regeneron Pharmaceuticals' Treasury Shares stood at $8.3 billion in 2021, then grew by 25.33% to $10.4 billion in 2022, then grew by 21.32% to $12.6 billion in 2023, then grew by 20.76% to $15.2 billion in 2024, then rose by 22.72% to $18.6 billion in 2025.
  • The last three reported values for Treasury Shares were $18.6 billion (Q4 2025), $17.9 billion (Q3 2025), and $17.3 billion (Q2 2025) per Business Quant data.